AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Silence Therapeutics Plc American Depository Share
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG00WVTHQK3
19.67▲ 0.01 (0.05%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
19.66
Day's Range
19.65 – 19.68
52-Week Range
4.17 – 19.69
Volume
2.1M
Avg Volume
4.0M
Share Statistics
Shares Outstanding
Employees
88
Exchange
XNAS
Listed
2020-09-08
Share count as of July 31, 2026

Silence Therapeutics Plc American Depository Share (SLN) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Silence Therapeutics Plc American Depository Share (SLN)
What is Silence Therapeutics Plc American Depository Share's Market Cap?
Silence Therapeutics Plc American Depository Share's Market Cap is $2.8B, based on as-reported figures from SEC (XBRL) filings.
What is Silence Therapeutics Plc American Depository Share's Enterprise Value?
Silence Therapeutics Plc American Depository Share's Enterprise Value is $2.7B, based on as-reported figures from SEC (XBRL) filings.
What is Silence Therapeutics Plc American Depository Share's Price / Sales?
Silence Therapeutics Plc American Depository Share's Price / Sales is 4533.4×, based on as-reported figures from SEC (XBRL) filings.
What is Silence Therapeutics Plc American Depository Share's EV / Revenue?
Silence Therapeutics Plc American Depository Share's EV / Revenue is 4416.2×, based on as-reported figures from SEC (XBRL) filings.
What is Silence Therapeutics Plc American Depository Share's EV / EBITDA?
Silence Therapeutics Plc American Depository Share's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Silence Therapeutics Plc American Depository Share's Revenue (TTM)?
Silence Therapeutics Plc American Depository Share's Revenue (TTM) is $615.0K, based on as-reported figures from SEC (XBRL) filings.
What is Silence Therapeutics Plc American Depository Share's Net Income (TTM)?
Silence Therapeutics Plc American Depository Share's Net Income (TTM) is -$60.0M, based on as-reported figures from SEC (XBRL) filings.
What is Silence Therapeutics Plc American Depository Share's EBITDA?
Silence Therapeutics Plc American Depository Share's EBITDA is -$68.0M, based on as-reported figures from SEC (XBRL) filings.
What is Silence Therapeutics Plc American Depository Share's Diluted EPS (TTM)?
Silence Therapeutics Plc American Depository Share's Diluted EPS (TTM) is -0.42, based on as-reported figures from SEC (XBRL) filings.
What is Silence Therapeutics Plc American Depository Share's EBITDA Margin?
Silence Therapeutics Plc American Depository Share's EBITDA Margin is -11057.6%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · SLNAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024
Revenue
YoY growth-100.0%+197.2%-99.9%-89.4%
Cost of sales
Gross profit
% of revenue—97.4%64.7%59.7%
Research and development costs
General and administrative expenses
Restructuring charges—
Operating loss
% of revenue—-3729.1%-36650.0%-16505.7%
Foreign currency gain/(loss), net
Other income, net
Benefit from R&D credit
Loss before income tax expense
Income tax expense
Net Loss
% of revenue—-3544.3%-34617.6%-13181.1%
Loss per share basic
Loss per share diluted